Back
Sarepta Therapeutics Stock Price Chart
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
128.15
Seasonality Move:
13.16%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 117.96 | Buy |
| 20-day SMA: | 123.22 | Buy |
| 50-day SMA: | 125.85 | Sell |
| 200-day SMA: | 111.41 | Buy |
| 8-day EMA: | 119.67 | Buy |
| 20-day EMA: | 121.74 | Buy |
| 50-day EMA: | 122.22 | Buy |
| 200-day EMA: | 115.77 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.98 | Sell |
| Relative Strength Index (14 RSI): | 54.02 | Buy |
| Chaikin Money Flow: | 1045395 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.38 - 128.56) | Buy |
| Bollinger Bands (100): | (100.69 - 131.03) | Buy |
Sarepta Therapeutics Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 124.25 while SRPT 8-day simple moving average is 117.96, which is a Buy signal.
- The stock price of SRPT is 124.25 while Sarepta Therapeutics 20-day SMA is 123.22, which makes it a Buy.
- Sarepta Therapeutics 50-day simple moving average is 125.85 while SRPT share price is 124.25, making it a Sell technically.
- SRPT stock price is 124.25 and Sarepta Therapeutics 200-day simple moving average is 111.41, creating a Buy signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $124.25. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
11.66B
Price in USD:
124.25
Share Volume:
1.34M
Sarepta Therapeutics 52-Week Range
52-Week High:
159.89
52-Week Low:
55.25
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 124.25 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 124.25 while SRPT 8-day exponential moving average is 119.67, which is a Buy signal.
- The stock price of SRPT is 124.25 while Sarepta Therapeutics 20-day EMA is 121.74, which makes it a Buy.
- Sarepta Therapeutics 50-day exponential moving average is 122.22 while SRPT share price is 124.25, making it a Buy technically.
- SRPT stock price is 124.25 and Sarepta Therapeutics 200-day simple moving average is 115.77, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.72 per share, an increase next quarter of $3.22 per share, an increase this year of $5.19 per share, and an increase next year of $7.23 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is -1.98, suggesting Sarepta Therapeutics is a Sell
- Sarepta Therapeutics Relative Strength Index (RSI) is 54.02, which suggest Sarepta Therapeutics is overbought
- The Bollinger Bands (25) for Sarepta Therapeutics is (119.38 - 128.56), which suggest Sarepta Therapeutics is a Buy
- The Bollinger Bands (100) for Sarepta Therapeutics is (100.69 - 131.03), which suggest Sarepta Therapeutics is a Buy
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.